GlobalData on MSN4d
R3 Vascular secures investigational device exemption for PAD treatmentThe company has announced that its new investigational device exemption will be used to launch a pivotal trial of its ...
The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.
GlobalData on MSN4d
FDA grants clearance for study of Envoy Medical’s cochlear implantUS-based Envoy Medical has received approval from the US Food and Drug Administration (FDA) for its investigational device ...
R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its drug-eluting ...
Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).
Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...
Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device ...
Envoy Medical (COCH) announces that its Investigational Device Exemption, IDE, application for its pivotal study of the Acclaim Fully Implanted ...
US-based bioabsorbable scaffold company, R3 Vascular, has been granted investigational device exemption (IDE) approval by the US Food and Drug Administration (FDA) to launch its ELITE-BTK pivotal ...
The Acclaim® Fully ImplantedCochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback